InTrack Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,831	Closed	-$370K	–	133
2024 Q1	$370K	Buy	6,831 +166	+2%	+$8.46K	0.27%	103
2023 Q4	$342K	Sell	6,665 -9,720	-59%	-$510K	0.26%	106
2023 Q3	$951K	Buy	16,385 +2,924	+22%	+$179K	0.84%	33
2023 Q2	$861K	Sell	13,461 -1,166	-8%	-$78.2K	0.7%	49
2023 Q1	$1.01M	Buy	14,627 +1,660	+13%	+$117K	0.92%	32
2022 Q4	$933K	Sell	12,967 -5,187	-29%	-$391K	0.93%	35
2022 Q3	$1.29M	Buy	18,154 +5,339	+42%	+$387K	1.43%	19
2022 Q2	$987K	Sell	12,815 -3,002	-19%	-$229K	1.01%	33
2022 Q1	$1.16M	Sell	15,817 -962	-6%	-$64.6K	0.94%	36
2021 Q4	$1.05M	Buy	16,779 +2,240	+15%	+$131K	0.72%	52
2021 Q3	$853K	Buy	14,539 +10,319	+245%	+$680K	0.62%	62
2021 Q2	$281K	Sell	4,220 -280	-6%	-$18.3K	0.22%	99
2021 Q1	$284K	Buy	+4,500	New	+$280K	0.26%	87